Related references
Note: Only part of the references are listed.Effects of native and modified low-density lipoproteins on monocyte recruitment in atherosclerosis
Christian A. Gleissner et al.
HYPERTENSION (2007)
Lipid-altering therapies and the progression of atherosclerotic disease
Anthony S. Wierzbicki
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2007)
Lipid-lowering efficacy of 3,4-Di(OH)-phenylpropionic L-leucine in high-cholesterol fed rats
SJ Kim et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2005)
Cholesterol metabolism and therapeutic targets: Rationale for targeting multiple metabolic pathways
SD Turley
CLINICAL CARDIOLOGY (2004)
α-asarone inhibits HMG-CoA reductase, lowers serum LDL-cholesterol levels and reduces biliary CSI in hypercholesterolemic rats
L Rodríguez-Páez et al.
PHYTOMEDICINE (2003)
Structural mechanism for statin inhibition of HMG-CoA reductase
ES Istvan et al.
SCIENCE (2001)
Synthesis and hypolipidemic and antiplatelet activities of α-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo)
J Poplawski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
